BD reports $19.5 billion in annual revenue for fiscal 2026
BD has posted a 4.9% increase in annual revenue to $19.5 billion for fiscal 2026, driven by a strong performance in the fourth quarter.
Medical technology firm BD recorded $19.5 billion in revenue for the full fiscal year 2026, representing a 4.9% increase compared to the previous year. In the fourth quarter, the company generated $5.3 billion in revenue, a 5.4% rise against the same period last year.
The company reported GAAP diluted earnings per share (EPS) of $5.06 for the fiscal year, with adjusted diluted EPS reaching $12.70. For the final quarter, GAAP diluted EPS was $2.52, while adjusted diluted EPS was $4.15.
BD’s growth reflects consistent demand across its medical technology segments. The company continues to focus on its operational efficiency as it integrates product portfolios and navigates global supply chain pressures. This performance aligns with market expectations for the sector.